Want to see IN:VISHNU full AI Analyst Report?
VISHNU Stock Chart & Stats
₹567.75
₹1.25(0.33%)
At close: 4:00 PM EST
₹567.75
₹1.25(0.33%)
Day’s Range― - ―
52-Week Range₹444.25 - ₹652.10
Previous CloseN/A
Volume59.33K
Average Volume (3M)8.04K
Market Cap
₹41.17B
Enterprise Value₹44.83B
Total Cash (Recent Filing)₹1.00B
Total Debt (Recent Filing)₹5.27B
Price to Earnings (P/E)29.5
Beta0.70
Next Earnings
Aug 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.05%
Share Statistics
EPS (TTM)21.19
Shares Outstanding67,315,285
10 Day Avg. Volume5,038
30 Day Avg. Volume8,045
Financial Highlights & Ratios
PEG Ratio2.33
Price to Book (P/B)3.08
Price to Sales (P/S)2.04
P/FCF Ratio-20.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)27.5
Revenue Forecast (FY)₹17.92B
Bulls Say, Bears Say
Bulls Say
End-market DiversificationExposure to multiple industrial end markets (pharma, pigments, leather, metal finishing) and both domestic and export customers supports demand resilience and reduces single-market cyclicality. This broad end-market mix helps stabilize volumes and provides cross-sector pricing levers over a multi-month horizon.
Revenue Recovery & ProfitabilityRecent revenue growth alongside healthy EBIT and net margins indicates core product demand and operational leverage. Sustained mid-teens operating profitability provides a structural earnings buffer, supporting reinvestment and creditor confidence if maintained across the next several quarters.
Improved Leverage & ReturnsMaterial deleveraging versus prior years and a moderate D/E ratio increase financial flexibility and lowers refinancing risk. Combined with a mid-teens ROE, the balance-sheet strengthening supports capacity to fund operations and investments more sustainably over a multi-quarter timeframe.
Bears Say
Weak Cash ConversionPersistent negative free cash flow and operating cash well below reported profits imply weak cash conversion from earnings, likely due to capex or working-capital build. That pattern raises funding risk, increases reliance on debt, and limits ability to self-fund growth or cushion shocks over coming quarters.
Margin CompressionA durable fall in gross margins versus prior years suggests sustained higher input costs, pricing pressure, or adverse mix shifts. If margins do not recover, earnings power is structurally impaired, reducing free cash potential and making the company more sensitive to raw-material inflation over the medium term.
Rising Absolute DebtAlthough leverage improved on a ratio basis, the rise in absolute debt levels increases interest and refinancing obligations. Coupled with weak free cash flow, higher nominal debt heightens liquidity and covenant risk, limiting strategic optionality and raising funding costs over the next several quarters.
Vishnu Chemicals Limited News
VISHNU FAQ
What was Vishnu Chemicals Limited’s price range in the past 12 months?
Vishnu Chemicals Limited lowest stock price was ₹444.25 and its highest was ₹652.10 in the past 12 months.
What is Vishnu Chemicals Limited’s market cap?
Vishnu Chemicals Limited’s market cap is ₹41.17B.
When is Vishnu Chemicals Limited’s upcoming earnings report date?
Vishnu Chemicals Limited’s upcoming earnings report date is Aug 03, 2026 which is in 18 days.
How were Vishnu Chemicals Limited’s earnings last quarter?
Vishnu Chemicals Limited released its earnings results on May 30, 2026. The company reported ₹6.49 earnings per share for the quarter, beating the consensus estimate of ₹5.2 by ₹1.29.
Is Vishnu Chemicals Limited overvalued?
According to Wall Street analysts Vishnu Chemicals Limited’s price is currently Overvalued.
Does Vishnu Chemicals Limited pay dividends?
Vishnu Chemicals Limited pays a Annually dividend of ₹0.3 which represents an annual dividend yield of 0.05%. See more information on Vishnu Chemicals Limited dividends here
What is Vishnu Chemicals Limited’s EPS estimate?
Vishnu Chemicals Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vishnu Chemicals Limited have?
Vishnu Chemicals Limited has 67,315,285 shares outstanding.
What happened to Vishnu Chemicals Limited’s price movement after its last earnings report?
Vishnu Chemicals Limited reported an EPS of ₹6.49 in its last earnings report, beating expectations of ₹5.2. Following the earnings report the stock price went down -0.69%.
Which hedge fund is a major shareholder of Vishnu Chemicals Limited?
Currently, no hedge funds are holding shares in IN:VISHNU
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vishnu Chemicals Limited
Founded in 1989 and headquartered in Hyderabad, India, Vishnu Chemicals Limited specializes in the manufacturing and global distribution of chromium and barium compounds. The company's extensive product line features various chrome-based chemicals, including sodium dichromate, chromic acid, chrome oxide green, basic chromium sulfate, sodium sulfate, and potassium dichromate, alongside barium carbonate. These essential chemicals serve a broad spectrum of industries, finding critical applications in pharmaceuticals, pigments, sports surfacing, leather processing, construction materials (such as equipment, roofing, and ceramic tiles), the automotive sector, decorative and functional plating, detergents, textiles, refractory brick production, and timber preservation. With its operational base in India, Vishnu Chemicals maintains a significant international footprint, supplying its offerings across Asia (including China and Southeast Asia), Europe (encompassing the United Kingdom), North America, South and Central America, Africa, and other worldwide markets.
Technical Analysis
Fineotex Chemical Limited
―
Laxmi Organic Industries Ltd.
―
Neogen Chemicals Ltd.
―
Rossari Biotech Ltd
―
Tatva Chintan Pharma Chem Limited
―